Endovia Health Sciences, Inc.
EDVA· NYSE
EDVAEndovia Health Sciences, Inc.
Filed Jul 11, 2025 · 10-K · 192 days after period end · 0001731122-25-000964
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $2.69M | $4.79M | $2.78M |
| Net Income | -$9.04M | -$5.99M | -$4.79M | -$5.88M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Jul 11, 2025 · 192 d after period end
